Evidence map›Paper›PMID 40269191›Full record

ArticleScientific reports2025

Aerosol emission and exposure in non-invasive ventilation.

Petra Nikuri, Anthony Maalouf, Ahmed Geneid, Eero Pesonen, Enni Sanmark, Ville A Vartiainen

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Petra NikuriHeart and Lung Center, Faculty of Medicine, Helsinki University Hospital, University of Helsinki, Helsinki, Finland. petra.nikuri@hus.fi.
Anthony MaaloufDepartment of Otorhinolaryngology ja Phoniatrics - Head and Neck Surgery, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Ahmed GeneidDepartment of Otorhinolaryngology ja Phoniatrics - Head and Neck Surgery, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Eero PesonenDepartment of Anesthesiology and Intensive Care Medicine, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Enni SanmarkHeart and Lung Center, Faculty of Medicine, Helsinki University Hospital, University of Helsinki, Helsinki, Finland.
Ville A VartiainenHeart and Lung Center, Faculty of Medicine, Helsinki University Hospital, University of Helsinki, Helsinki, Finland.

Funding

Business Finland 4793/31/2021
6 · The paper itself

Abstract

From the beginning of the COVID-19 pandemic, there has been concern among clinicians whether the use of high-flow nasal cannula (HFNC) and continuous positive airway pressure (CPAP) contributes to aerosol generation and consequently spreading of pathogens. Most guidelines still classify these treatments as high-risk aerosol-generating procedures. The aim of this study was to evaluate differences in aerosol emissions and exposure with CPAP and HFNC compared to no breathing aid (NBA). Aerosol emissions of 16 healthy volunteers using CPAP, HFNC and NBA were measured with a portable aerosol spectrometer. During each measurement, the volunteers were instructed consecutively to breathe normally, breathe deeply, cough and read aloud a predefined text. The Wilcoxon signed-rank test was used in statistical analysis. Non-invasive ventilation (CPAP, HFNC) does not produce significantly more aerosol than the same respiratory activities without a breathing aid (median CPAP-NBA - 4.54 1/L, p = 0.816, and HFNC-NBA 2.27 1/L, p = 0.244), deep breathing (median CPAP-NBA - 2.27 1/L, p = 0.378 and HFNC-NBA 4.55 1/L, p = 0.623), speaking (median CPAP-NBA 0 1/L, p = 0.0523 and HFNC-NBA 9.09 1/L, p = 0.0140), or coughing (median CPAP-NBA - 17.31 1/L, p = 0.587 and HFNC-NBA 1.92 1/L, p = 0.365). The results indicate that both CPAP and HFNC have no clinically meaningful impact on aerosol emission. Therefore, the use of CPAP or HFNC does not expose healthcare personnel to greater concentrations of aerosols when compared to normal breathing in healthy participants.

Indexed as

Continuous Positive Airway PressureCOVID-19Noninvasive VentilationAdultAerosolsCannulaFemaleHealthy VolunteersHumansMaleMiddle AgedSARS-CoV-2Young AdultAerosolsAerosol emissionContinuous positive airway pressure (CPAP)High-Flow nasal cannula (HFNC)Respiratory aerosols

Identifiers

PMID40269191
PMCPMC12019220

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.